• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.78% Nasdaq Down1.13%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    9.19 Down 0.57(5.84%) 4:00PM EDT
    |After Hours : 9.19 0.00 (0.00%) 4:32PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 22,392   13,795   44,901   8,562  
    Cost of Revenue -   -   -   -  
    Gross Profit 22,392   13,795   44,901   8,562  
    Operating Expenses
    Research Development37,567  31,733  33,984  22,749  
    Selling General and Administrative14,373  12,459  13,329  7,890  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (29,548) (30,397) (2,412) (22,077)
    Income from Continuing Operations
    Total Other Income/Expenses Net384  347  190  200  
    Earnings Before Interest And Taxes(29,164)(30,050)(2,222)(21,877)
    Interest Expense -   -   -   -  
    Income Before Tax(29,164)(30,050)(2,222)(21,877)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(29,164)(30,050)(2,222)(21,877)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (29,164) (30,050) (2,222) (21,877)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (29,164) (30,050) (2,222) (21,877)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.